CCM
Consonance Capital Management Portfolio holdings
AUM
$7.28M
This Quarter Return
+18.45%
1 Year Return
-42.86%
3 Year Return
+319.33%
5 Year Return
+899.35%
10 Year Return
–
AUM
$1.11B
AUM Growth
+$1.11B
(+22%)
Cap. Flow
+$165M
Cap. Flow
% of AUM
14.88%
Top 10 Holdings %
Top 10 Hldgs %
77.46%
Holding
28
New
8
Increased
10
Reduced
5
Closed
5
Top Buys
| 1 |
RDUS
Radius Health, Inc.
RDUS
|
$84.2M |
| 2 |
MiMedx Group
MDXG
|
$75.5M |
| 3 |
argenx
ARGX
|
$49.5M |
| 4 |
Savara
SVRA
|
$40.9M |
| 5 |
NUVA
NuVasive, Inc.
NUVA
|
$39.5M |
Top Sells
Sector Composition
| 1 | Healthcare | 92.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SPPI
1
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $140M | 12.64% | 7,383,466 -1,325,665 | -15% | -$25.1M |
|
2
Corcept Therapeutics
CORT
$7.35B
| $104M | 9.43% | 5,779,506 +1,897,283 | +49% | +$34.3M |
|
|
AMRN
3
Amarin Corp
AMRN
$311M
| $98.2M | 8.87% | 24,476,520 -172,760 | -0.7% | -$693K |
|
|
GWPH
4
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $89.2M | 8.05% | 675,492 +73,445 | +12% | +$9.7M |
|
|
RDUS
5
DELISTED
Radius Health, Inc.
RDUS
| $84.2M | 7.6% | +2,649,285 | New | +$84.2M |
|
6
Travere Therapeutics
TVTX
$1.56B
| $76.8M | 6.94% | 3,644,438 +138,834 | +4% | +$2.93M |
|
|
7
MiMedx Group
MDXG
$1.05B
| $75.5M | 6.82% | +5,990,682 | New | +$75.5M |
|
8
Pacira BioSciences
PCRX
$1.2B
| $73.1M | 6.61% | 1,602,334 +222,200 | +16% | +$10.1M |
|
|
LJPC
9
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $66.9M | 6.04% | 2,079,311 +76,792 | +4% | +$2.47M |
|
|
10
argenx
ARGX
$43.6B
| $49.5M | 4.47% | +783,869 | New | +$49.5M |
|
|
11
Savara
SVRA
$567M
| $40.9M | 3.69% | +2,756,012 | New | +$40.9M |
|
|
NUVA
12
DELISTED
NuVasive, Inc.
NUVA
| $39.5M | 3.57% | +675,000 | New | +$39.5M |
|
|
STML
13
DELISTED
Stemline Therapeutics, Inc.
STML
| $36.7M | 3.31% | 2,349,792 +2,248,372 | +2,217% | +$35.1M |
|
14
UroGen Pharma
URGN
$900M
| $34.1M | 3.08% | +916,450 | New | +$34.1M |
|
15
Pacific Biosciences
PACB
$393M
| $18.7M | 1.68% | 7,065,920 +164,492 | +2% | +$434K |
|
16
Vericel Corp
VCEL
$1.83B
| $18.4M | 1.66% | 3,381,303 +356,969 | +12% | +$1.95M |
|
17
Catalyst Pharmaceutical
CPRX
$2.52B
| $17.5M | 1.58% | 4,473,607 +4,104,309 | +1,111% | +$16M |
|
|
OXFD
18
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $15.6M | 1.41% | +1,119,887 | New | +$15.6M |
|
19
ADMA Biologics
ADMA
$4.12B
| $10.8M | 0.98% | 3,367,635 +2,093,702 | +164% | +$6.72M |
|
20
ANI Pharmaceuticals
ANIP
$2.03B
| $9.22M | 0.83% | 142,978 -25 | -0% | -$1.61K |
|
|
CVRS
21
DELISTED
CORINDUS VASCULAR ROBOTICS, INC
CVRS
| $6.05M | 0.55% | 5,986,005 -5,877,348 | -50% | -$5.94M |
|
22
Iovance Biotherapeutics
IOVA
$807M
| $1.86M | 0.17% | +232,396 | New | +$1.86M |
|
|
SPNE
23
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $217K | 0.02% | 21,428 -22,199 | -51% | -$225K |
|
24
Globus Medical
GMED
$8.27B
| – | – | -554,699 | Closed | -$16.5M |
|
25
Myriad Genetics
MYGN
$593M
| – | – | -1,973,177 | Closed | -$71.4M |
|